ETV5 and neoplasm: The phosphorylation of a conserved N-terminal threonine residue, in combination with ERM binding to PI(4, 5) P2, is needed for functional activation or ERM proteins [57] Thus, NSC668394 treatment has been shown to prevent actin binding, resulting in several physiological effects, such as reduced cell migration, cell invasion and tumor growth [40].